|
|
Medical Professionals
NIH Funding
The National Institutes of Health (NIH) became interested in vulvodynia towards the late 1990s. The NVA worked together with several NIH Institutes in 1997 to organize and support the first Vulvodynia Workshop: Current Knowledge and Future Direction. The goals of this conference were to bring together a multidisciplinary group of clinicians and researchers to exchange information on what was currently known about the disorder and to develop research priorities for the future.
In 1998, the National Institute of Child Health and Human Development (NICHD) issued its first Program Announcement on vulvodynia. In early 2000, the NICHD and Office of Research on Women's Health issued the first Request for Application. (Click here for a summary of NIH funding mechanisms currently available.)
To date, the NIH has funded the following studies:
Click on the underlined study titles for additional information.
 |
Gloria Bachmann, MD
Associate Dean for Women's Health
UMDNJ-Robert Wood Johnson Medical School
Vulvodynia Prevalence And Efficacy Of 4 Interventions (2000 - 2005)
|
 |
Gregory Essick, DDS, PhD
Professor, School of Dentistry
University of North Carolina - Chapel Hill
Phenotyping Core of Complex Persistent Pain Conditions
|
 |
Melissa Farmer, BA, PhDc
McGill University
Mouse model of vestibulodynia using recurrent vulvovaginal Candidiasis (2008 - 2010)
|
 |
David Foster, MD, MPH
Associate Professor of Obstetrics and Gynecology
University of Rochester School of Medicine
Vulvar vestibulitis trial: Desipramine-Lidocaine (2002 - 2007) |
 |
Bernard L. Harlow, PhD
Professor and Head
Division of Epidemiology and Community Health
University of Minnesota School of Public Health
Prevalence And Etiological Predictors Of Vulvodynia (2000 - 2005)
Immunological Factors and Risk of Vulvodynia (2009 - 2012)
|
 |
Colleen Kennedy, MD
Assistant Professor of Obstetrics and Gynecology
University of Iowa Carver College of Medicine
Vulvar Disease and Bladder and Bowel Symptoms (2004 - 2008)
|
 |
William Maixner, DDS, PhD
Director of the Center for Neurosensory Disorders
University of North Carolina - Chapel Hill
Complex Persistent Pain Conditions: Unique and Shared Pathways of Vulnerability
|
 |
Robin Masheb, PhD
Assistant Professor of Psychiatry
Yale University School of Medicine
Cognitive-Behavioral Therapy For Vulvodynia (2000 - 2003)
|
 |
Andrea Nackley Neely, PhD
Assistant Professor of Pharmacology, Center for Neurosensory Disorders
University of North Carolina
Molecular Profiling Core of Complex Persistent Pain Conditions
|
 |
Barbara Reed, MD
Professor of Family Medicine
University of Michigan Medical School
Neuroimmunology/Cytokine Alterations In Vulvodynia (2000 - 2003)
Midcareer Vulvodynia Research and Mentoring Project (2003 - 2008)
Longitudinal Population-Based Study of Vulvodynia (2008 - 2013)
Characterization of Pain Processing in Vulvodynia (2005 - 2007)
|
 |
Peter Smith, PhD
Director, Department of Molecular & Integrative Physiology
The University of Kansas Medical Center
Female Pelvic Pain, Hormones and Neuroplasticity (2006 - 2011)
|
 |
Frank Tu, MD, MPH
Director, Division of Endoscopic Surgery and Chronic Pelvic Pain
North Shore University Health System
Novel Pelvic Floor Pain Measures to Enhance Female Pelvic Pain Evaluation (2008 - 2013)
|
 |
Ursula Wesselmann, MD, PhD
Professor of Anesthesiology
University of Alabama at Birmingham
Mechanisms of Vulvodynia (2001 - 2006) |
 |
Jackie Wood, PhD
Professor of Physiology and Cell Biology
Ohio State University College of Medicine
Function of the Enteric Nervous System
|
 |
Denniz Zolnoun, MD
Assistant Professor of Obstetrics and Gynecology
University of North Carolina - Chapel Hill
Refining Diagnostic Criteria of a Pain Disorder: Vulvar Vestibulitis Syndrome (2006 - 2011)
VVS: Subproject 2 of Complex Persistent Pain Conditions
|
The National Vulvodynia Association is a nonprofit organization that strives to improve women's lives through education, support, advocacy and research
funding. The NVA is not a medical authority and strongly recommends that you consult your own health care provider regarding any course of treatment or medication.
Last Updated on February 2, 2012
|
